Sildenafil and Pharma: A Volatile Opportunity?

The history of Sildenafil presents a complex picture for those considering investment. While the initial introduction generated significant returns, the expiration of its patent opened the avenue to off-brand competitors, dramatically eroding sales. This presents a specific risk for drug manufact

read more